Drawing upon deep industry knowledge and transactional experience, Naschitz Brandes Amir lawyers provide comprehensive counsel to companies at all stages of growth as well as entrepreneurs and investors focused on the medical device sector.


Through an interdisciplinary approach, we serve the needs of our medical device clients across a broad spectrum of practices, including product development, company formation, patent prosecution and protection, venture financing, intellectual property transactions, licensing, data protection, privacy, and use and transmissions of data, M&A, IPO and securities law matters.



How we help our clients:


  • Venture Formation
  • Technology Licensing
  • Joint Ventures and Partnerships
  • Clinically Integrated Networks
  • Mergers and Acquisitions
  • System Acquisition
  • SaaS and PaaS Agreements
  • Digital Asset Management
  • IP and Brand Protection
  • IT Outsourcing and Procurement
  • Data Protection and Cyber Security
  • Data Governance

FIMI Opportunity Funds

Advised FIMI, a leading Israeli private equity firm, on the sale of 33% of the shares in Simplivia Healthcare to The Phoenix Holdings and Leumi Partners.


Simplivia Healthcare

Represented Simplivia Healthcare, a global developer of medical devices, in its acquisition of 70% of the share capital of Novamed.


Femi Medical Services and the Davidoff Group

Advised Femi Medical Services and the Davidoff Group on the NIS 200 million acquisition of Kedma Capital’s control in Femi Premium by G Square.


Cardiovascular Systems

Represented US-based Cardiovascular Systems (NASDAQ: CSII) in its acquisition of the WIRION Embolic Protection System and related assets from Allium Medical (TASE: ALMD) and it's subsidiary Gardia Medical.



Advised EyeControl, an assistive communication technology startup on its $10 million funding round. We also represent the company in its ongoing corporate activity and privacy-related matters.


MEDCu Technologies

Advised MEDCu Technologies, a provider of copper-based wound dressing products, in a SAFE financing round.


Syqe Medical

Advise Syqe Medical, a provider of next-generation precision inhalers, on day-to-day operations and strategic matters, including partnership agreements, manufacturing agreements, and complex funding structures.



Advise MagBiosense, a US-based diagnostic device company, on a commercial agreement with the Israeli Ministry of Health for the development and distribution of rapid test kits for COVID-19.


Ornim Medical

Advised Ornim Medical, a developer of non-invasive patient monitoring solutions, on its $20 million Series C financing.

matching results
  • 10 January 2022

    Naschitz Brandes Amir Advises MeMed on $93 Million Series E